Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Beginning Cash Balance (2011 - 2020)

Volitionrx posted quarterly Beginning Cash Balance of $17.0 million for Q1 2020, up 26.36% year-on-year from $13.4 million in Q2 2019, and up 26.36% on a QoQ basis from $13.4 million in Q1 2019.

Volitionrx (VNRX) has 5 years of Beginning Cash Balance data on file, last reported at $17.0 million in Q1 2020.

  • For the quarter ending Q1 2020, Beginning Cash Balance rose 26.36% year-over-year to $17.0 million; the trailing twelve-month figure through Mar 2020 stood at $30.4 million (up 125.86% YoY), and the FY2013 full-year result was $54396.0, down 46.96% from the prior year.
  • Beginning Cash Balance for Q1 2020 stood at $17.0 million, up from $13.4 million in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $17.0 million in Q1 2020 and bottomed at $13.4 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2020 16.97 Mn
Mar 31, 2020 16.97 Mn
Mar 31, 2019 13.43 Mn
Mar 31, 2019 13.43 Mn
Dec 31, 2013 53,075.00
Dec 31, 2013 53,075.00
Mar 31, 2013 1,321.00
Mar 31, 2013 1,321.00
Dec 31, 2012 102,560.00
Dec 31, 2012 102,560.00
Dec 31, 2011 545,244.00
Dec 31, 2011 545,244.00
Sep 30, 2011 -97,213.00
Sep 30, 2011 -97,213.00
Jun 30, 2011 -100,000.00
Jun 30, 2011 -100,000.00
Mar 31, 2011 -58,594.00
Mar 31, 2011 -58,594.00